S21 S Afr Fam Pract ISSN 2078-6190 EISSN 2078-6204 © 2019 The Author(s) NW REFRESHER COURSE Introduction Opioids have been the cornerstone of analgesia under anaesthesia since the 1960’s and were introduced to provide haemodynamic stability in this setting.1 The routine use of synthetic opioids, although rarely questioned, should be supported with evidence which favours patient outcomes in the perioperative period.2 As physicians, best practice evidence guides our hand in rendering favourable outcomes to our patients. Therefore, it is prudent to question whether or not there are alternative methods to managing pain in the perioperative setting. Why opioid free anaesthesia? Opioids have served anaesthesiologists well in rendering haemodynamic stability and reduced nociception to their patients, but have also caused many complications because of their side effect profile and the candid nature with which they are used. This unconsidered use of opioids has led to the so called ‘opioid crisis’.3,4 What is the opioid crisis? In the United States, doctors prescribe and patients consume a staggering 80% of the world’s supply of opioids despite only making up approximately 4.4% of the world’s population.5 In just over a decade, opioid prescriptions quadrupled and opioid related deaths surpassed motor vehicle accidents as the leading cause of accidental death.6,7 Since the treatment of pain is constitutionally a basic human right, and costs nations millions in medical treatment and loss of productivity, there has been a pendulum swing unintentionally towards the increased use of opioids. However, this has led to the overwhelming overuse and abuse of opioids that is now deemed to be ‘in crisis’.5 As Anaesthetists, we play an important role in the promulgation of this crisis through postsurgical pain management. Retrospective studies show that between 3% and 7% of opioid naïve surgical patients still use opioids their first year after surgery.8,9 The risk of chronic opioid abuse is significantly increased in surgical patients when compared to non-surgical patients10 and it is therefore the responsibility of the perioperative physician to add good governance to prescription practices so as to curve the added risk of potential addiction to postoperative patients. To reduce the burden of hospital discharge, doctors are incentivised to overprescribe post hospital opioids. This results in up to 72% of the pills prescribed going unused by general surgical patients.11 It has been shown that this strategy leads to opioids falling into the wrong hands and exacerbates drug addiction problems.12,13 Therefore, opioids are under the spotlight as a leading cause of morbidity and have consequences that are not only patient specific, but affect society and the economy. The reason behind opioids being so addictive and propagating this knock-on effect is because of the pathophysiological process known as neuroadaptation. Neuroadaptation The major features of opioid addiction are tolerance, withdrawal and compulsive use and relapse. These are thought to be brought about by a large range of neuroadaptations in response to chronic opioid exposure.14 Adaptations to opioid exposure are considered to occur at different levels in the nervous system and include: • tolerance at the mu-opioid receptor • cellular tolerance and withdrawal in opioid-sensitive neurons • systems tolerance and withdrawal in opioid-sensitive nerve networks • synaptic plasticity in opioid-sensitive nerve networks Tolerance to opioids is characterised by a reduced clinical response to opioid agonists, manifesting as increasing dose requirements to achieve the desired effect. Mechanisms of receptor regulation appear to be enhanced as a result of receptor tolerance and include desensitisation and internalisation.14 Cellular tolerance is more complex and several processes are involved which include the upregulation of cAMP/PKA and cAMP response signalling as well as the mitogen PK cascade.14 The complex neuropharmacology of neuroadaptation is out of the scope of this discussion, but is important to the understanding of why opioid free anaesthesia (OFA) may offer better anaesthetic care in the face of the opioid crisis. Furthermore, neuroadaptation is just one of many consequences to opioid use peri-operatively and thereby supports efforts to seek alternative perioperative analgesic practices. South African Family Practice 2019; 61(2):S21-S24 Open Access article distributed under the terms of the Creative Commons License [CC BY-NC-ND 4.0] http://creativecommons.org/licenses/by-nc-nd/4.0 Opioid Free Anaesthesia: a paradigm shift Anamourlis PC Department of Anaesthesia, Chris Hani Baragwanath Academic Hospital,University of the Witwatersrand, South Africa Corresponding author, email: chris.anamourlis@gmail.com S Afr Fam Pract 2019;61(2)22 S22 The threat of opioids The consequences of opioid administration intra- and postoperatively are not benign or uncommon and include: • Nausea and vomiting • Sedation • Ileus • Confusion/delirium • Respiratory depression • Increased postoperative pain and morphine consumption15 • Immunodepression • Potential hyperalgesia • Chronic postoperative pain • Addiction Hypoxaemia, ileus and confusion/delirium are among the most commonly seen complications, which are associated with significant morbidity.1 Hypoxaemia This is a frequent complication post-anaesthesia and occurs within minutes after extubation. Patients undergoing abdominal surgeries have a high incidence of postoperative hypoxaemia, between 20%-40%16,17 which is attributed largely to the use of drugs such as opioids.18 In the USA, it is well described that a large majority of closed claims are the result of severe postoperative respiratory depression occurring within the first 24 hours post- surgery.19 Ileus Postoperative ileus and its sequelae are one of the most important causes of prolonged hospitalisation from abdominal surgery. This is further complicated by the use of opioids that are often needed to manage pain.1 More serious complications of ileus include: • Gastrointestinal perforation • Nosocomial infections • Malnourishment • Muscular atrophy Complications exacerbated by the concomitant use of opioids in patients with ileus include: • Bowel dysfunction • Postoperative ileus in non-abdominal procedures • Prolonged recovery The incidence of ileus can be as high as 10%, as shown in recent reviews and was higher when higher doses of morphine was used.1,20 Delirium and postoperative cognitive dysfunction (POCD) Delirium and POCD are common in geriatric patients (5%- 15% and 25%-40%, respectively), especially those coming for arthroplasty procedures. Delirium is associated with further cognitive decline that may lead to accelerated onset of dementia.21,22 Furthermore, they are associated with a longer length of stay and discharge to monitored care environments. Overall, the incidence of 1 year mortality is higher in this patient population. Postoperative opioid analgesic practice in this group of at-risk patients is of particular concern, as the administration of intravenous opioids has been shown to significantly increase the risk of elderly arthroplasty patients developing POCD.20 Krenk et al.23 showed that fast track set ups that disallow for prolonged hospital stays and utilise opioid-sparing or opioid-free practice, avoids the development of delirium post operatively and hence reduces the risk of POCD and mortality.23 Acute tolerance/hyperalgesia The more opioids given intraoperatively, the more the postoperative analgesic requirements: this is termed the ‘opioid paradox’ and can be explained through acute tolerance and neuroadaptive processes caused by short acting opioids or chronic opioid use. It has therefore been suggested by several authors that the fewer opioids given intraoperatively the less opioid will be required postoperatively, because mu-receptor integrity is maintained.24 Therefore, the revolutionary status that opioids have held because of their usefulness in creating a balanced anaesthetic now appears to be under duress. The rising evidence in favour of opioid restricted or non-opioid anaesthesia, although scarce, appears promising. Furthermore, in the context of enhanced recovery programmes, there is congruency and synergism with OFA that negates the negative effects opioids have had in abdominal procedures. OFA has therefore been pushed into the spotlight as a potential solution to perioperative analgesic management that extends beyond its use in only abdominal surgeries. Opioid Free Anaesthesia The basis of successful fast-track surgery is the use of efficacious multimodal analgesia and anaesthesia, and has been recommended for over a decade now to negate the potential deleterious effects of opioid overuse/abuse. These multimodal, opioid avoiding drug regimens aim to decrease intraoperative and postoperative opioid requirements, decrease postoperative pain, and hence hasten recovery through avoidance of potential side effects caused by opioids.25 Opioid-free anaesthesia (OFA) is a multimodal anaesthetic practice that utilises: • Hypnotics • Gabapentinoids • N-methyl-D-aspartate (NMDA) antagonists • local anaesthetics • anti-inflammatory drugs • alpha-2 agonists The abovementioned OFA drugs were discussed in last year’s North West Refresher notes and hence will not be repeated here.26 Instead, the focus of this discussion is to inform about specific OFA protocols and debate whether we should be practicing them. Opioid Free Anaesthesia: a paradigm shift 23 S23 Concerns over providing haemodynamic stability with OFA are abated by evidence provided in the first studies concerning OFA, which focused on bariatric patients. The use of dexmedetomidine, was shown to significantly reduce postoperative pain and opioid requirements in this patient population, without causing respiratory depression.27,28 Furthermore, the use of dexmedetomidine permits haemodynamic stability under anaesthesia, due to its unique spinal and supraspinal mode of action. Several studies27,28 have gone on to show the positive effects of OFA with dexmedetomidine, which include: • sparing of other anaesthetic agents • improved haemodynamic stability • reduced bleeding • prevention of shivering • non-delayed emergence • attenuated postoperative pain • reduced postoperative opioid consumption • reduction in postoperative nausea and vomiting • prevention and treatment of hyperalgesia The significance of hypotension and bradycardia caused by dexmedetomidine is yet to be determined, as there is no evidence currently on the consequences of the use of alpha-2 agonists intraoperatively.2 Loco-regional anaesthesia also forms part of OFA principles, as they negate the need for intraoperative and postoperative opioids. Peripheral nerve blocks and epidurals improve pain management significantly. Furthermore, epidurals have been shown to prevent, independently from the use of opioids, postoperative hyperalgesia.29 Local anaesthetic adjuncts now also include alpha-2 agonists in their armamentarium, and thus provide safer block prolongation without the unwanted side effects of opioids.2 Ketamine has an important role in OFA, as its use improves the management of postoperative pain, through its analgesic, anti- hyperalgesic properties and haemodynamic safety profile.2 To further abate concerns over providing a haemodynamically stable anaesthetic with OFA, adding magnesium sulphate to OFA protocols, is shown to not only augment the analgesic action of lignocaine and ketamine, but importantly reduces heart rate variability without causing hypotension.2 The abovementioned drugs form part of most OFA regimens and are not complete without the mention of intravenous lignocaine. Lignocaine use intravenously is advocated in major surgeries, especially abdominal surgeries, because of its complimentary effects to enhanced recovery programs i.e. anti-inflammatory properties, pro-peristaltic action, sympathetic blockade and acute analgesic action. Although scarce, the available evidence advocating opioid sparing techniques is in favour of their use. However, it is not clear whether there is overall benefit to completely abdicating the use of opioids. The Postoperative and Opioid Free Anaesthesia (POFA) randomised-controlled trial is underway (NCT03316339)1, and hopes to test the superiority of OFA techniques, but to also test non-inferiority and safety of OFA.1 Perhaps the most famous protocol to date is the Bruge Protocol developed at Sint Jan Bruge to treat patients coming for major bariatric surgeries. OFA Protocol Sint Jan Brugge with Dex Three drugs (Dex 200ug, Ket 50 mg, Lid 300 mg, add H20 to 20 ml) given at 1 ml/10 kg IBW and followed by 1 ml/10 kg IBW/h adapt to HR/MAP • Dexmedetomidine 0,5 to 1 ug/kg IBW followed by 0,5 to 1 ug/ kg IBW/h • Ketamine 0,125 to 0,25 mg/kg followed by 0,125 to 0,25 mg/ kg IBW/h • Lidocaine 1,5 mg/kg IBW followed by 1,5 to 3 mg/kg IBW/h Magnesium sulphate 40 mg/kg IBW followed by 10 mg/kg IBW/h Propofol is given at 2,5 mg/kg IBW followed by inhalation anesthesia at 0,6 - 0,8 MAC with BIS around 40%. Rocuronium 0,6 - 1 mg/kg IBW followed by infusion 1 mg/ kg IBW/h and based on TOF PTC (if NMB is needed). Postoperative analgesia Non-steroidal anti-inflammatory agents • Paracetamol 2 g loading 1 g/6h • Diclofenac 150 mg loading, 2x75 mg/day • Or Keterolac 40 mg loading, 3 x 10 mg/day Local wound infiltration (calculate toxic dose!) Choice between: • Continue with clonidine 2 x 75 ug/day or give low dose morphine OR • Keep infusion of sympatholytic mixture (ket dex lido Mg) at low dose without deep sedation ▪ Ketamine 0,05 mg/kg/h ▪ Lidocaine 1 mg/kg/h ▪ MgSO4 10 mg/kg/h ▪ Dexmedetomidine 0,1 - 0,2 ug/kg/h Monitoring and ensuring safe OFA One of the valid concerns, regarding OFA, is the lack of adequate tools to monitor nociception (sympathetic/parasympathetic balance). This, however, brings into question how accurate any nociceptive monitoring is, especially since it is not routine and anaesthetists rely mainly on the haemodynamic status to address ‘pain’ under anaesthesia.24 Noxious stimuli from surgical stress induces neuro-humoral activation and therefore cardiovascular and pulmonary effects that can be objectively monitored and documented through standard ASA monitoring under anaesthesia. This is effective in monitoring opioid-based anaesthetic practice, but is not specific to surgical stimulus and nociceptive activation exclusively.24 The ‘pain matrix’ or brain network responsible for the sensory processing of nociception and pain is associated not only with cortical activity but sub-cortical activity too, thus making it a highly complex network. Therefore, monitors such as BIS or Entropy, which monitor processed cortical EEG brain activity, S Afr Fam Pract 2019;61(2)24 S24 do not asses the effects of nociception. This is corroborated by Lichtner et al. who demonstrated that propofol cannot alter noxious stimuli effects at the spinal level nor at midbrain level, even at burst suppression doses.24 What tools do we have then, to monitor the stress response effects, when using OFA? Autonomic system evaluation The measurement of sympathetic activity and heart rate variability through skin conductance methods as well as surgical plethysmography index tools have shown some promise in detecting acute pain in anaesthetised patients, however their accuracy clinically has never been shown to be clinically significant.30 More recently, a French company, Metrodoloris, has been promoting the use of the Analgesia Nociceptive Index (ANI), which is promoted as a potential tool to aid the assessment of acute nociception and pain.24 ANI works on the basis of raw ECG data that is derived from the use of two ANI electrodes that are applied in the V1 and V5 positions on the chest. Frequency domain-based analysis of the high frequency component of HRV combined with respiratory rate computes the ANI, which is displayed as a number from 0-100. The values reflect predominance in parasympathetic tone, with low numbers being low tone and high numbers being high parasympathetic predominance.31,32 Despite there being a large number of publications regarding ANI-guidance for intraoperative opioid administration, there is weak evidence supporting that it improves pain post-operatively. This makes it less likely to be useful as a tool for monitoring pain in the setting of OFA anaesthesia.24 Conclusion In conclusion, the scarcity of evidence supporting the use of OFA in place of opioid based anaesthetic practice means that the obvious feasibility of OFA is not sufficient to be recommended formally. Yet, specific adverse outcomes from OFA in the literature are absent. This calls into question the added value of opioid use at all, since the use of opioids have such potential for adverse events postoperatively. The lack of research in a wide range of surgical procedures means that opioids still form the basis of perioperative analgesia, however, they have fallen out of favour in enhanced recovery programmes, due to the obvious benefits of OFA. This see-saw is where we are currently at determining the place of OFA and the POFA trial hopes to shed more light on this controversial topic. References 1. Beloeil  H, Laviolle  B, Menard  C, Paugam-Burtz C, Garot M, Asehnoune K, et  al. POFA trial study protocol: a multicentre, doubleblind, randomised, controlled clinical trial comparing opioid-free versus opioid anaesthesia on postoperative opioid-related adverse events after major or intermediate non-cardiac surgery. BMJ Open. 2018;8:e020873. 2. Forget P. Opioid-free anaesthesia: Why and how? A contextual analysis. Anaesth Crit Care Pain Med. 2018;38:169-172. 3. Kharasch ED, Brunt LM. Perioperative opioids and public health. Anesthesiology. 2016;124:960-5. 4. Kamdar NV, Hoftman N, Rahman S, Cannesson M. Opioid-free analgesia in the era of enhanced recovery after surgery and the surgical home: implications for postoperative outcomes and population health. Anesth Analg. 2017;125:1089-91. 5. Stone AB, Wick Ec, Wu CL, et al. The US Opioid Crisis: A Role for Enhanced Recovery After Surgery. Anesth Analg. 2017;125(5).1803-05. 6. Drug overdose deaths in the United States continue to increase in 2015. Available at: https://www.cdc.gov/drugoverdose/ epidemic/. Accessed January 31, 2017. 7. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378–82. 8. Clarke H, Soneji N, Ko DT, Yun L, Wijeysundera DN. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ. 2014;348:g1251. 9. Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012;172:425–30. 10. Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med. 2016;176:1286–93. 11. Hill MV, McMahon ML, Stucke RS, Barth RJ Jr. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265:709–14. 12. Waljee JF, Li L, Brummett CM, Englesbe MJ. Iatrogenic opioid dependence in the United States: are surgeons the gatekeepers? Ann Surg. 2017;265:728–30. 13. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers— United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013;132:95-100. 14. Christie MJ. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol. 2008;154:384-96. 15. Chia YY, Liu K, Wang JJ, Kuo MC, Ho ST. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anesth. 1999;46(9):872-7. 16. Xue FS, Li BW, Zhang GS, Liao X,  Zhang YM,  Liu JH,  An G,  Luo LK. The influence of surgical sites on early postoperative hypoxemia in adults undergoing elective surgery. Anesth Analg. 1999;88:213-9. 17. Reeder MK, Goldman MD, Loh L,   Muir AD,  Foëx P,  Casey KR,  McKenzie PJ. Postoperative hypoxaemia after major abdominal vascular surgery. Br J Anaesth. 1992;68:23-6. 18. Canet J, Ricos M, Vidal F. Early postoperative arterial oxygen desaturation. Determining factors and response to oxygen therapy. Anesth Analg. 1989;69:207-12. 19. Lee LA, Caplan RA, Stephens LS, Posner KL, Terman GW, Voepel-Lewis T, Domino KB. Postoperative opioid-induced respiratory depression: a closed claims analysis. Anesthesiology. 2015;122:659-65. 20. Wang Y, Sands LP, Vaurio L, Mullen EA, Leung JM. The effects of postoperative pain and its management on postoperative cognitive dysfunction. Am J Geriatr Psychiatry. 2007;15:50-9. 21. Crosby G, Culley DJ, Dexter F. Cognitive outcome of surgery: is there no place like home? Anesth Analg. 2014;118:898-900. 22. Card E, Pandharipande P, Tomes C, Lee C, Wood J, Nelson D, et al. Emergence from general anaesthesia and evolution of delirium signs in the post-anaesthesia care unit. Br J Anaesth. 2015;115:411-7. 23. Krenk L, Kehlet H, Bæk Hansen T, Solgaard S, Soballe K, Rasmussen LS. Cognitive dysfunction after fast-track hip and knee replacement. Anesth Analg. 2014;118:1034-40. 24. Lavand’homme P, Estebe J-P. Opioid-free anaesthesia: a different regard to anaesthesia practice. Curr Opin Anesthesiology. 2018;31:556-61. 25. Canet J, Gallart L, Gomar C, Paluzie G, Vallès J, Castillo J, et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113:1338-50. 26. Leonard TGA. Non-opioid analgesic options. South African Family Practice. 2018;60(4):S17-S20. 27. Feld JM, Hoffman WE, Stechert MM, Hoffman IW, Ananda RC. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18:24-8. 28. Hofer RE, Sprung J, Sarr MG, Wedel DJ. Anesthesia for a patient with morbid obesity using dexmedetomidine without narcotics. Can J Anaesth. 2005;52:176-80. 29. Lavand’homme P, De Kock M, Waterloos H. Intraoperative epidural analgesia combined with ketamine provides effective preventive analgesia in patients undergoing major digestive surgery. Anesthesiology. 2005;103:813-20. 30. Ledowski T, Sommerfield D, Slevin L, Conrad J, von Ungern-Sternberg BS. Surgical pleth index: prediction of postoperative pain in children? Br J Anaesth. 2017;119(5):979-83. 31. Le Guen M, Jeanne M, Sievert K, Chazot T, Laloë PA, Dreyfus JF, et al. The analgesia nociception index: a pilot study to evaluation of a new pain parameter during labor. Int J Obstet Anesth. 2012; 21: 146-51. 32. Jeanne M, Logier R, De Jonckheere J, Tavernier B. Validation of a graphic measurement of heart rate variability to assess analgesia/nociception balance during general anaesthesia. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:1840-3.